About this document
In Brief: Gasdermin B in IBD and Epithelial Barrier Repair by veronicaanguyenanhanhminhca is a document available to read on EtoBox.
A phase III trial showed that nivolumab combined with chemotherapy or ipilimumab significantly improves overall survival in patients with advanced oesophageal squamous cell carcinoma compared to chemotherapy alone. Additionally, research on gasdermin B indicates its increased expression in patients with inflammatory bowel disease (IBD) plays a crucial role in epithelial barrier repair, although mutations in GSDMB may impair these processes. A UK study found that immunosuppressive IBD treatments affect immun
- Author
- veronicaanguyenanhanhminhca
- Language
- EN